Hikma Cuts $50M Deal To End Antitrust Claims In Xyrem MDL

By Dorothy Atkins · May 8, 2025, 6:30 PM EDT

A certified class of Xyrem buyers in 36 states have asked a California federal judge to preliminarily approve Hikma Pharmaceuticals PLC's $50 million deal to resolve antitrust claims accusing Hikma of...

To view the full article, register now.